Literature DB >> 836208

Closed vitreous surgery: XV. Fibrovascular ingrowth from the pars plana sclerotomy.

Y M Tardif, C L Schepens.   

Abstract

Ten eyes developed fibrovascular ingrowth from the sclerotomy following closed vitreous surgery. The complication was detected by examining all patients postoperatively by indirect ophthalmoscopy and biomicroscopy with a three-mirror lens. The average follow-up was 13.2 months. Nine patients had proliferative retinal disease prior to surgery and related systemic disease. In six eyes, useful vision was lost due to the ingrowth. In three eyes, a stabilization occurred. In one eye, that of a 12-year-old girl with an undefined syndrome of cochlear and retinal neovascularization, the ingrowth involuted. Rubeosis iridis was observed in 6 eyes that developed vascular ingrowth as opposed to 11 eyes in a control group of 78 eyes. Eyes with rubeosis iridis should not have vitreous surgery, and careful dissection of the Tenon capsule should be done over the sclerotomy.

Entities:  

Mesh:

Year:  1977        PMID: 836208     DOI: 10.1001/archopht.1977.04450020036006

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  4 in total

1.  Macular morphologic findings on optical coherence tomography after microincision vitrectomy for proliferative diabetic retinopathy.

Authors:  Tomoaki Murakami; Akihito Uji; Ken Ogino; Noriyuki Unoki; Shin Yoshitake; Yoko Dodo; Takahiro Horii; Kazuaki Nishijima; Nagahisa Yoshimura
Journal:  Jpn J Ophthalmol       Date:  2015-05-09       Impact factor: 2.447

Review 2.  The pars plana incision: experimental studies, pathologic observations, and clinical experience.

Authors:  A E Krieger
Journal:  Trans Am Ophthalmol Soc       Date:  1991

3.  Fibrovascular ingrowth and recurrent haemorrhage following diabetic vitrectomy.

Authors:  J F West; Z J Gregor
Journal:  Br J Ophthalmol       Date:  2000-08       Impact factor: 4.638

4.  Digitally assisted vitreoretinal surgery: A unique surgical teaching tool for beginners.

Authors:  Dhipak Arthur; Naresh Babu Kannan; Sagnik Sen; Kim Ramasamy
Journal:  Indian J Ophthalmol       Date:  2022-02       Impact factor: 2.969

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.